dysgerminoma
dysgerminoma
Explore linked clinical trials. Standard reference: MONDO:00030021 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Nonseminomatous germ cell tumor, dysgerminoma, germinoma, germinomatous germ cell tumor, neoplasm, seminoma | Active, not recruiting | Phase 2 | 2026-09-18 | NCT03158064 |